US Stock MarketDetailed Quotes

MRKR Marker Therapeutics

Watchlist
  • 3.7150
  • +0.0950+2.62%
Trading Aug 28 12:55 ET
33.15MMarket Cap-3175P/E (TTM)

Marker Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
12.37%-3.57M
-23.85%-3.84M
51.93%-10.34M
43.84%-2.3M
83.47%-867.18K
-6,643.44%-4.07M
74.66%-3.1M
21.14%-21.51M
15.53%-4.1M
30.39%-5.25M
Net income from continuing operations
46.51%-2.19M
43.36%-2.39M
28.97%-14.05M
9.96%-2.74M
47.93%-2.98M
-274.22%-4.1M
57.37%-4.22M
52.78%-19.78M
68.83%-3.04M
53.93%-5.73M
Other non cash items
----
----
----
----
----
----
----
---278.68K
--0
----
Change In working capital
-1,071.48%-1.44M
-426.46%-1.52M
159.76%2.85M
120.24%292.11K
1,202.48%1.94M
-90.96%147.97K
109.76%466.74K
-187.05%-4.76M
-155.12%-1.44M
-106.71%-175.94K
-Change in receivables
-289.64%-638.69K
-358.10%-823.65K
157.22%1.37M
-31.00%-944.5K
257.85%1.66M
153.85%336.79K
16,481.83%319.12K
-340.10%-2.4M
-12,016,516.67%-720.99K
-2,449,844.19%-1.05M
-Change in prepaid assets
-70.16%-467.39K
95.10%71.12K
726.82%861.11K
205.23%941.23K
50.53%158.11K
54.04%-274.68K
-87.36%36.45K
124.41%104.15K
42.31%308.37K
4.54%105.03K
-Change in payables and accrued expense
-486.01%-331.42K
-793.69%-771.18K
146.32%611.26K
139.10%402.91K
-98.53%11.32K
-97.03%85.86K
102.81%111.17K
-131.87%-1.32M
-173.65%-1.03M
-70.67%772.41K
-Change in other working capital
----
----
----
----
----
----
----
-200.00%-1.15M
--0
--0
Cash from discontinued investing activities
0
0
-11.73%-6.1M
97.14%-62.94K
89.15%-260.28K
-2.99M
-2.79M
-5.46M
-2.2M
-2.4M
Operating cash flow
49.44%-3.57M
34.83%-3.84M
39.05%-16.44M
62.45%-2.37M
85.25%-1.13M
-787.95%-7.06M
51.84%-5.89M
1.13%-26.97M
-29.79%-6.31M
-1.46%-7.65M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow
--0
--0
477.42%18.66M
--0
--0
928.54%18.78M
95.41%-112.61K
-57.93%-4.95M
63.60%-127.34K
89.86%-99.37K
Financing cash flow
Cash flow from continuing financing activities
5,960.60%44.61K
-92.08%49.1K
446.74%1.11M
-96.29%5.14K
479.27K
-98.84%736
619.97K
-99.62%202.13K
138.56K
0
Net common stock issuance
--36.9K
--0
401.97%1.01M
--0
--394.67K
--0
--619.97K
-99.62%202.13K
--138.56K
--0
Proceeds from stock option exercised by employees
946.74%7.7K
--49.1K
--90.48K
--5.14K
--84.61K
--736
--0
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
5,960.60%44.61K
-92.08%49.1K
446.74%1.11M
-96.29%5.14K
--479.27K
-98.84%736
--619.97K
-99.62%202.13K
--138.56K
--0
Net cash flow
Beginning cash position
76.89%11.32M
28.26%15.11M
-72.91%11.78M
-3.33%17.47M
-29.82%18.12M
-77.79%6.4M
-72.91%11.78M
103.71%43.5M
-62.89%18.08M
-54.87%25.82M
Current changes in cash
-130.06%-3.52M
29.60%-3.79M
110.50%3.33M
62.47%-2.36M
91.63%-648.19K
491.04%11.72M
63.34%-5.38M
-243.22%-31.72M
-20.86%-6.29M
9.05%-7.75M
End cash Position
-56.96%7.8M
76.89%11.32M
28.26%15.11M
28.26%15.11M
-3.33%17.47M
-29.82%18.12M
-77.79%6.4M
-72.91%11.78M
-72.91%11.78M
-62.89%18.08M
Free cash flow
49.44%-3.57M
34.83%-3.84M
39.05%-16.44M
62.45%-2.37M
85.25%-1.13M
-525.74%-7.06M
59.88%-5.89M
11.31%-26.97M
-21.07%-6.31M
10.22%-7.65M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 12.37%-3.57M-23.85%-3.84M51.93%-10.34M43.84%-2.3M83.47%-867.18K-6,643.44%-4.07M74.66%-3.1M21.14%-21.51M15.53%-4.1M30.39%-5.25M
Net income from continuing operations 46.51%-2.19M43.36%-2.39M28.97%-14.05M9.96%-2.74M47.93%-2.98M-274.22%-4.1M57.37%-4.22M52.78%-19.78M68.83%-3.04M53.93%-5.73M
Other non cash items -------------------------------278.68K--0----
Change In working capital -1,071.48%-1.44M-426.46%-1.52M159.76%2.85M120.24%292.11K1,202.48%1.94M-90.96%147.97K109.76%466.74K-187.05%-4.76M-155.12%-1.44M-106.71%-175.94K
-Change in receivables -289.64%-638.69K-358.10%-823.65K157.22%1.37M-31.00%-944.5K257.85%1.66M153.85%336.79K16,481.83%319.12K-340.10%-2.4M-12,016,516.67%-720.99K-2,449,844.19%-1.05M
-Change in prepaid assets -70.16%-467.39K95.10%71.12K726.82%861.11K205.23%941.23K50.53%158.11K54.04%-274.68K-87.36%36.45K124.41%104.15K42.31%308.37K4.54%105.03K
-Change in payables and accrued expense -486.01%-331.42K-793.69%-771.18K146.32%611.26K139.10%402.91K-98.53%11.32K-97.03%85.86K102.81%111.17K-131.87%-1.32M-173.65%-1.03M-70.67%772.41K
-Change in other working capital -----------------------------200.00%-1.15M--0--0
Cash from discontinued investing activities 00-11.73%-6.1M97.14%-62.94K89.15%-260.28K-2.99M-2.79M-5.46M-2.2M-2.4M
Operating cash flow 49.44%-3.57M34.83%-3.84M39.05%-16.44M62.45%-2.37M85.25%-1.13M-787.95%-7.06M51.84%-5.89M1.13%-26.97M-29.79%-6.31M-1.46%-7.65M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow --0--0477.42%18.66M--0--0928.54%18.78M95.41%-112.61K-57.93%-4.95M63.60%-127.34K89.86%-99.37K
Financing cash flow
Cash flow from continuing financing activities 5,960.60%44.61K-92.08%49.1K446.74%1.11M-96.29%5.14K479.27K-98.84%736619.97K-99.62%202.13K138.56K0
Net common stock issuance --36.9K--0401.97%1.01M--0--394.67K--0--619.97K-99.62%202.13K--138.56K--0
Proceeds from stock option exercised by employees 946.74%7.7K--49.1K--90.48K--5.14K--84.61K--736--0--0--0--0
Cash from discontinued financing activities
Financing cash flow 5,960.60%44.61K-92.08%49.1K446.74%1.11M-96.29%5.14K--479.27K-98.84%736--619.97K-99.62%202.13K--138.56K--0
Net cash flow
Beginning cash position 76.89%11.32M28.26%15.11M-72.91%11.78M-3.33%17.47M-29.82%18.12M-77.79%6.4M-72.91%11.78M103.71%43.5M-62.89%18.08M-54.87%25.82M
Current changes in cash -130.06%-3.52M29.60%-3.79M110.50%3.33M62.47%-2.36M91.63%-648.19K491.04%11.72M63.34%-5.38M-243.22%-31.72M-20.86%-6.29M9.05%-7.75M
End cash Position -56.96%7.8M76.89%11.32M28.26%15.11M28.26%15.11M-3.33%17.47M-29.82%18.12M-77.79%6.4M-72.91%11.78M-72.91%11.78M-62.89%18.08M
Free cash flow 49.44%-3.57M34.83%-3.84M39.05%-16.44M62.45%-2.37M85.25%-1.13M-525.74%-7.06M59.88%-5.89M11.31%-26.97M-21.07%-6.31M10.22%-7.65M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg